Perfluorooctanesulfonate Induces Hepatomegaly and Lipoatrophy in Mice through Phosphoenolpyruvate Carboxykinase-Mediated Glyceroneogenesis Inhibition | |
Wang, Ling; Cao, Huiming; Zhou, Zhen; Pan, Yu; Liu, Guangliang; Wang, Thanh; Wang, Yawei; Xiao, Mingwei; Chen, Siyi; Liang, Yong | |
刊名 | ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS
![]() |
2020-03 | |
卷号 | 7期号:3页码:185-190 |
ISSN号 | 2328-8930 |
英文摘要 | Perfluorooctansulfonate (PFOS) is a persistent organic pollutant that has attracted a great deal of attention due to toxic effects such as its lipid metabolism-disrupting potential. Exposure to PFOS can cause hepatomegaly and lipoatrophy in mice, but the underlying mechanisms are still unknown. Considering that glyceroneogenesis is the essential pathway for balancing the triglyceride (TG) cycle between liver and white adipose tissue (WAT), we speculate that PFOS acts via glyceroneogenesis inhibition to alter TG metabolism in the two tissues. Combining gene expression, protein expression, an enzyme activity assay, and molecular docking analysis, we report here that PFOS can interact with cytosolic phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme of glyceroneogenesis. Specifically, by repression of PEPCK, PFOS can inhibit the glyceroneogenesis process and thus decrease the glyceroneogenesis-derived glycerol level, leading to a reduced re-esterified TG level and causing atrophy in WAT. Moreover, in PFOS-exposed liver tissue, despite the fact that free glycerol and fatty acids released from WAT were being used for TG synthesis, the export of TG slowed. This eventually resulted in the continuous lipolysis of WAT and accumulation of lipid in the liver. PEPCK can be used as a key biomarker to assess the lipid metabolism disorders induced by other conventional and emerging per- and polyfluoroalkyl substances. |
内容类型 | 期刊论文 |
源URL | [http://ir.rcees.ac.cn/handle/311016/44771] ![]() |
专题 | 生态环境研究中心_环境化学与生态毒理学国家重点实验室 |
推荐引用方式 GB/T 7714 | Wang, Ling,Cao, Huiming,Zhou, Zhen,et al. Perfluorooctanesulfonate Induces Hepatomegaly and Lipoatrophy in Mice through Phosphoenolpyruvate Carboxykinase-Mediated Glyceroneogenesis Inhibition[J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS,2020,7(3):185-190. |
APA | Wang, Ling.,Cao, Huiming.,Zhou, Zhen.,Pan, Yu.,Liu, Guangliang.,...&Liang, Yong.(2020).Perfluorooctanesulfonate Induces Hepatomegaly and Lipoatrophy in Mice through Phosphoenolpyruvate Carboxykinase-Mediated Glyceroneogenesis Inhibition.ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS,7(3),185-190. |
MLA | Wang, Ling,et al."Perfluorooctanesulfonate Induces Hepatomegaly and Lipoatrophy in Mice through Phosphoenolpyruvate Carboxykinase-Mediated Glyceroneogenesis Inhibition".ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS 7.3(2020):185-190. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论